4.8 Review

Protease-Activated Drug Development

期刊

THERANOSTICS
卷 2, 期 2, 页码 156-178

出版社

IVYSPRING INT PUBL
DOI: 10.7150/thno.4068

关键词

Protease; activatable probe; Alzheimer's disease; cancer; caspase; cathepsin; kallikrein; MMP; PSA; serine protease; aspartyl protease

资金

  1. National Institutes of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH)
  2. NIH [K99/R00]

向作者/读者索取更多资源

In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据